An open-label, prospective interventional study of the tolerability and efficacy of 0.4 mg oral tamsulosin oral controlled absorption system in men with lower urinary tract symptoms associated with benign prostatic hyperplasia who are unsatisfied with treatment with 0.2 mg tamsulosin

PURPOSE: The aim of this study was to investigate the efficacy and tolerability of switching from 0.2 mg tamsulosin to 0.4 mg tamsulosin oral controlled absorption system (OCAS) over a 12-week period in Taiwanese men with lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplas...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Pei-Shan, Chen, Chien-Lun, Hou, Chen-Pang, Lin, Yu-Hsiang, Tsui, Ke-Hung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808696/
https://www.ncbi.nlm.nih.gov/pubmed/29445269
http://dx.doi.org/10.2147/CIA.S152701

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5808696/
https://www.ncbi.nlm.nih.gov/pubmed/29445269
http://dx.doi.org/10.2147/CIA.S152701

Ejemplares similares